The Palantir of Biotech: This tiny, NVIDIA-backed firm is building the world’s most advanced AI supercomputer, which can compress years of drug development into just months. This is a pure “picks and shovels” play that is poised to explode once Trump’s AI Mandate takes effect. A similar infrastructure play, GeneDx, soared up to 16,800% this year!
The #1 Biotech Royalty Play: A disruptive AI firm that’s building what NVIDIA calls the “world-leading physics-based platform” for accelerated drug discovery. This firm has partnerships with Eli Lilly, Novartis and some of the biggest players in biotech… and they receive a cut from all the sales their drugs generate. This one play could potentially hand you biotech royalties for life.
Dylan’s AI Biotech Moonshot: This AI-powered biotech firm could dethrone the world’s most lucrative drug, Merck’s Keytruda (which generates over $29 billion a year in sales). According to Fierce Pharma, their drug “crushes” Merck’s competing product. A similar stock has recently just soared 178% in a day. And this $20 stock is poised for a big breakout as well.

If you’re not 100% satisfied with Biotech Insider, simply contact us within the first 30 days and you’ll get a full refund of your membership fee.

***Remember, Trump’s AI Mandate could take effect just days from now…

It’s poised to force 6,653 U.S. biotech firms to adapt AI into their operations…

And AI biotech stocks are already taking off.

Seven out of the twenty best performing stocks this year came out of biotech…

Including winners like 942%... 1,677%...

And the best performing stock of 2025, which soared up to 16,800%

That’s the potential you’re looking at with Dylan’s AI biotech recommendations.

Simply put, there’s no telling how high these three stocks could go.

But you must act now, before Trump’s historic AI Mandate takes effect.

This is a rare, once-in-a-deace opportunity…

You’ll not get a second chance.

That means today could be your last chance to close the financial gap between where you are and where you want to be.

So don’t put this off.

Just a few months from now, your life could be completely transformed, just like what already happened to some of Dylan’s readers.

To get started, fill out the new member acceptance form below.

Lifetime Subscription

$9,997 $2,997 (for a limited-time only!)

This option grants you access to Biotech Insider -- for life.

For just a little bit more than an annual subscription, you'll receive access to our most exclusive investment advisory service forever. Every month, you will receive Dylan's pick of the best biotech stocks on the market.

Two Year Subscription

$5,994 $2,497

Renews: $2,497 per two year thereafter

Join for two years and save more than $2,497 off your membership -- that's a tremendous savings and guarantees you at least 24 monthly issues of Biotech Insider research reports -- plus our 30-day money-back guarantee!

One Year Subscription

$3,000 $1,997

Renews: $1,997 / year

Subscribe now for one year and you will save over $1,000 off your first year's membership -- that's a tremendous savings and guarantees you at least 12 monthly issues of Biotech Insider research reports - plus our 30-day money-back guarantee!

First Name

This field is required.

Last Name

This field is required.

Please enter valid email address.

Confirm Email

Email fields must match.

Phone Number

This field is required.

Street Address

This field is required.

City

This field is required.

State

This field is required.

Postal Code

This field is required.

Card Number

Please enter a valid card number.

Exp. Month - MM

This field is required.

Exp. Year - YYYY

This field is required.

CVC

This field is required.